Fate Therapeutics (FATE) Insider Trading & Ownership $1.42 -0.12 (-7.77%) As of 02:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Fate Therapeutics (NASDAQ:FATE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$668,579.52Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$25,352.29 Get FATE Insider Trade Alerts Want to know when executives and insiders are buying or selling Fate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FATE Insider Buying and Selling by Quarter Fate Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/10/2025Bahram ValamehrCEOSell8,705$1.54$13,405.70 1/10/2025Jerome Charles BressiInsiderSell5,980$1.55$9,269.00 12/20/2024Redmile Group, LlcDirectorBuy397,964$1.68$668,579.52 8/6/2024Yuan XuDirectorSell633$4.23$2,677.59 (Data available from 1/1/2013 forward) FATE Insider Trading Activity - Frequently Asked Questions Who is on Fate Therapeutics's Insider Roster? The list of insiders at Fate Therapeutics includes Bahram Valamehr, Brian T Powl, Cindy Tahl, Edward J Dulac III, J Scott Wolchko, Jerome Charles Bressi, John Mendlein, Mark Plavsic, Redmile Group, Llc, Shefali Agarwal, Yuan Xu, and Yu-Waye Chu. Learn more on insiders at FATE. What percentage of Fate Therapeutics stock is owned by insiders? 5.00% of Fate Therapeutics stock is owned by insiders. Learn more on FATE's insider holdings. Which Fate Therapeutics insiders have been buying company stock? The following insider purchased FATE shares in the last 24 months: Redmile Group, Llc ($1,108,603.12). How much insider buying is happening at Fate Therapeutics? Insiders have purchased a total of 488,294 FATE shares in the last 24 months for a total of $1,108,603.12 bought. Which Fate Therapeutics insiders have been selling company stock? The following insiders have sold FATE shares in the last 24 months: Bahram Valamehr ($62,772.68), Brian T Powl ($18,768.98), Cindy Tahl ($47,519.38), Edward J Dulac III ($78,196.82), J Scott Wolchko ($62,888.67), Jerome Charles Bressi ($9,269.00), Yuan Xu ($24,329.11), and Yu-Waye Chu ($16,635.24). How much insider selling is happening at Fate Therapeutics? Insiders have sold a total of 81,109 Fate Therapeutics shares in the last 24 months for a total of $320,379.88 sold. Fate Therapeutics Key ExecutivesMr. J. Scott Wolchko (Age 54)Founder, CEO, President & Director Compensation: $920.4kMr. Edward J. Dulac III (Age 48)Chief Financial Officer Compensation: $612.5kMs. Cindy R. Tahl J.D. (Age 51)General Counsel, Corporate Secretary & Compliance Officer Compensation: $612.5kDr. Bahram Valamehr Ph.D. (Age 47)Chief Research & Development Officer Compensation: $644.5kMr. Jim Beitel M.B.A.Senior Vice President of Corporate DevelopmentDr. Jerome Bressi Ph.D.Senior Vice President of Regulatory & QualityDr. Barbara HickingbottomSenior VP of Clinical Development More Insider Trading Tools from MarketBeat Related Companies AnaptysBio Insider Selling Kura Oncology Insider Selling CorMedix Insider Selling ORIC Pharmaceuticals Insider Selling Rapport Therapeutics Insider Selling Septerna Insider Selling Precigen Insider Selling Stoke Therapeutics Insider Selling Cullinan Therapeutics Insider Selling Xeris Biopharma Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:FATE) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FATE Stock Alerts